Publication | Closed Access

Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1–31)NH2] in postmenopausal women with osteoporosis

Pharmacokinetic ProfileMedicineParathyroid HormoneGynecologyMenopauseParathyroid GlandEndocrinologyPharmacologyOsteoporosisOrthopaedic SurgeryWomen's HealthPostmenopausal Women